Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle.
Increased interest in development of combined gene therapy emerges from results of recent clinical trials that indicate good safety yet unexpected low efficacy of "single-gene" administration. Multiple studies showed that vascular endothelial growth factor 165 aminoacid form (VEGF165) and...
Enregistré dans:
Auteurs principaux: | Pavel Makarevich, Zoya Tsokolaeva, Alexander Shevelev, Igor Rybalkin, Evgeny Shevchenko, Irina Beloglazova, Tatyana Vlasik, Vsevolod Tkachuk, Yelena Parfyonova |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ccb99f37a0ce4bbca79c397bebfc1c9c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure.
par: Antti Siltanen, et autres
Publié: (2011) -
A Fluorescent Aptasensor Based on Assembled G-Quadruplex and Thioflavin T for the Detection of Biomarker VEGF165
par: Xin Zheng, et autres
Publié: (2021) -
PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
par: Tianrun Liu, et autres
Publié: (2018) -
Anti-angiogenic effects of VEGF stimulation on endothelium deficient in phosphoinositide recycling
par: Amber N. Stratman, et autres
Publié: (2020) -
Endothelial Semaphorin 3fb regulates Vegf pathway-mediated angiogenic sprouting.
par: Charlene Watterston, et autres
Publié: (2021)